The most recent policy would empower Medicare to negotiate the cost for 10 of the most expensive drugs by 2025 and 20 drugs per year by 2028. (Photo: Shutterstock)
After months of haggling, congressional Democrats on Tuesday reached a scaled-back agreement on drug pricing reform. The proposal would allow Medicare Part D to negotiate directly with pharmaceutical companies.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
